Merck & Co., Inc. Earnings: 1 Sentence That Changed Everything
Merck's fourth-quarter earnings results were more or less as expected, but this one sentence completely threw Wall Street and investors for a loop!
Why Achillion Pharmaceuticals, Inc. Stock Is Crashing Today
Shares of this clinical-stage biotech are crashing today. Here's why.